AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04074083 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: electronic IMCI
Description: Participants will be trained to use an electronic version of the Integrated Management of Childhood Illness (IMCI) guidelines
Study NCT04074083 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: paper IMCI
Description: Participants will be trained to use routine paper version of Integrated Management of Childhood Illness (IMCI) guidelines
Study NCT06398002 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dialysate calcium 1.50 mmol/L
Description: Increased dialysate calcium of 1.50 mmol/L (as compared to standard dialysate calcium of 1.25 mmol/L)
Study NCT06398002 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dialysate calcium 1.50 mmol/L
Description: Increased dialysate calcium of 1.50 mmol/L (as compared to standard dialysate calcium of 1.25 mmol/L)
Study NCT05193968 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Sympathoexcitatory stressors
Description: Muscle sympathetic nerve activity will be measured continuously at baseline and in response to sympathoexcitatory stressors, including a Valsalva maneuver, isometric handgrip exercise, a cold pressor test, and stepped hypercapnia.
Study NCT05193968 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Sodium Nitroprusside
Description: Sodium nitroprusside, used to test endothelium-independent vasodilation, will be infused through a brachial artery catheter at 0.25, 0.5, 1.0 and 2.0 ug/100ml tissue/min.
Study NCT05193968 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Acetylcholine
Description: Acetylcholine, used to test endothelium-dependent vasodilation, will be infused through a brachial artery catheter at 1.0, 2.0, 4.0, and 8.0 μg/100ml tissue/min
Study NCT05193968 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Terbutaline
Description: Terbutaline, a β2-Adrenergic selective agonist, will be infused through a brachial artery catheter at 0.1, 0.5, 1.0, and 2.0 μg/100ml tissue/min.
Study NCT05193968 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Norepinephrine
Description: Norepinephrine, an α-adrenergic vasoconstricting agent, will be infused through a brachial artery catheter at 1.0, 2.0, 4.0, and 8.0 ng/100ml tissue/min
Study NCT05689489 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Puzzle Method
Description: While preparing the puzzle to be used in the study, the puzzle preparation program will be used (Crossword Puzzle Maker). Students in the initiative group will be asked to solve a total of 6 puzzles, one puzzle each week. The answers to the prepared puzzles will cover the theoretical course topics of psychiatric nursing. In the puzzles, students will be expected to place their answers in the specified rows and columns. Students will be asked to solve puzzles individually. In addition, the answer to each puzzle will be found on the reverse on the back page. Students will be reminded that there is no time limit for solving the puzzles. Researchers will guide students while students solve puzzles.
Study NCT05689489 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Ongoing Education
Description: Students in the control group will only take the theoretical course of psychiatric nursing.
Study NCT04616170 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hip extension
Description: Hips extended at the time of vaginal delivery
Study NCT04616170 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Hips positioned in the usual care position per provider preference at the time of vaginal delivery
Study NCT05034809 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melatonin 20 MG
Description: Melatonin, also known as N-acetyl-5-methoxytryptamine will be the main intervention given to participating patients of this study. This study will use a dose of 20mg/day using the commercially available 5mg/tablet20-21. If a patient cannot be tolerate swallowing the whole tablet, it will be crushed and mixed with milk. According to the study done by Shah et al. there was no degradation in the active component of melatonin when mixed with milk or food as a medium for drug delivery.
Study NCT05196750 — intervention group
Intervention type: OTHER
Intervention: Behavioural questionnaires and assessments on mother and child
Description: Questionnaires include, but not limited to, State Trait Anxiety Inventory, Beck Depression Inventory, LYNDON Maternal Health and Well Being, Facial Imitation Task, Deferred Imitation, Habituation, Relational Binding, Behavioural Observation, Mirror Self Recognition, Standardized Assessment and Experimental Task, Snack and Sticker Delay, Implicit Attitude Test
Study NCT05157906 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Education based
Description: The interventional materials will be provided digitally for 12 weeks, with the monthly theme featured from the educational Grow Happy book and related tips and videos that will be released weekly.
Study NCT05157906 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: At enrollment, subject will be provided with the Mother and Child booklet, which is the Indonesian standard of care for parenting guidance.
Study NCT06345365 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mitoxantrone liposome, Ara-Cytarabine and azacitidine
Description: Mitoxantrone hydrochloride liposome 24 mg/m2, IV every 4 weeks, day 1; Ara-Cytarabine 100 mg/m2, IV every 12 h, days 1-7; Azacitidine 100 mg, subcutaneous, once daily, days 1 to 7
Study NCT06345365 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Daunorubicin,Ara-Cytarabine, azacitidine
Description: Daunorubicin 60 mg/m2, intravenously, once daily, days 1 to 3; Ara-Cytarabine 100 mg/m2, IV drip, every 12h, days 1 to 7; Azacitidine 100 mg, subcutaneous, once daily, days 1 to 7;
Study NCT06168786 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fruquintinib
Description: Fruquintinib:5mg ,qd,po, d1-d14, q3w
Study NCT06168786 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cadonilimab
Description: Cadonilimab:10mg/kg, ivgtt, d1, q3w
Study NCT06168786 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: SBRT
Description: SBRT:8-10Gy×5F，qod， in 10 days
Study NCT05591586 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Web based educational modules
Description: This strategy will consist of 6 web-based modules, clinic-specific interpreter access information, and 4 booster modules, all delivered via the internet. The online modules will cover 6 topics: 1) the importance and fundamentals of good communication; 2) the importance of professional interpreter use and disparities for LEP populations; 3) how to use an interpreter effectively; 4) what to do when the encounter is not going well; and 5) special challenges and 6) solutions related to remote interpreter use. Modules will be interactive, with tailoring to the learner, and each will be \<15 minutes long. All modules will be available at once, but assigned providers will be prompted to view a new one each week. Every month for months 3-6 after randomization, a booster module will be released. The brief (\<10 min) boosters will review crucial points from initial modules and feature video vignettes. Providers will be reminded to view these weekly until they are complete.
Study NCT05591586 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mobile video interpreting (mVI) access
Description: This strategy will involve giving assigned providers access to mobile video interpreting (mVI) on a personal device, installation and support as needed, a tip sheet, and an extra charger, optional shock-resistant case, disposable antimicrobial sleeves, and a positioning stand to support use of their personal device for clinical care. mVI-assigned providers can opt for a study-issued smartphone in lieu of using their own. Access to mVI is achieved by downloading the application from the relevant location (e.g., Apple App Store), then entering an access code that links to a billing account. The study staff would then demonstrate use and answer questions. Technical support will be offered in-person following randomization; we will then email mVI-assigned providers weekly for the first month, then monthly, to offer additional support. A tip-sheet will be sent via email during the first week of the study that will include mVI instructions and best-practices.
Study NCT04227353 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HEAL ABC
Description: Participants will be assigned their first booklet based on the one they perceive to be the easiest for setting an incremental goal and achieving it. After the participant achieves successful behaviour change, he or she can move more confidently to the next booklet. Support will be provided every two weeks over the phone for 12 weeks. During the follow-up period, participants will use the follow-up booklet which helps them to continue with changes they have made and encourage them to set new goals.
Study NCT05940155 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: RT PCR test of COVID 19
Description: diagnostic test by naso-pharyngel swab to confirm the diagnosis of covid-19 at moderate and severe cases.
Study NCT06162130 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Eccentric quadriceps exercises
Description: The activation of the vastus medialis, vastus lateralis, and rectus femoris muscles will be measured using surface electromyography (sEMG) during four distinct quadriceps eccentric exercises: Reverse Nordic, Pistol squat, Suspension-based Bulgarian split squat, and Bulgarian split squat. Participants will be instructed to perform three successful repetitions for each exercise. A 30-second break will be provided between each repetition, and there will be a minimum of 10 minutes of rest between each of the four exercises. Due to the belief that fatigue could impact exercise performance, the modified Borg scale will be used to ensure that fatigue does not occur before each exercise. Exercise recording will commence when scores reported using the modified Borg scale are 1 or lower.
Study NCT05558423 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Time Restricted Eating
Description: Participants are asked to follow a Time Restricted Eating regimen with eating window of ≤10 hours.
Study NCT03813433 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Revascularization
Description: a procedure used to regenerate pulp dentin complex that restores the functional properties of this immature anterior teeth, prevent and resolves apical periodontitis
Study NCT03813433 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Revascularization
Description: a procedure used to regenerate pulp dentin complex that restores the functional properties of this immature anterior teeth, prevent and resolves apical periodontitis
Study NCT04809493 — intervention group
Intervention type: PROCEDURE
Intervention: Conventional dialysis treatment
Description: Conventional dialysis treatment
Study NCT04809493 — intervention group
Intervention type: PROCEDURE
Intervention: Isonatremic dialysis treatment
Description: Isonatremic dialysis treatment
Study NCT06270446 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Community based physiotherapy
Description: Physiotherapy at community rehabilitation center
Study NCT06270446 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Outpatient physiotherapy
Description: Physiotherapy at hospital
Study NCT06269692 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: MRI screening
Description: Cardiac Magnetic Resonance imaging for the quantification of the infarct intramural scar
Study NCT06269692 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MRI screening
Description: Cardiac Magnetic Resonance imaging for the quantification of the infarct intramural scar
Study NCT06269692 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Implantable Loop Recorder
Description: Inplantation of the Implantable Loop Recorder (ILR) for the patients assigned to the experimental group
Study NCT06269692 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Implantable Cardioverter Defibrillator
Description: Inplantation of the Implantable Cardioverter Defibrillator (ICD) for the patients assigned to the control group, according to the current guidelines
Study NCT01906411 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Intervention: Dopamine depletion vs. Balanced aminoacid drink
Study NCT04816981 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EBUS-Elastography
Description: Patients undergoing LN staging for lung cancer with EBUS-TBNA will have digital images and biopsy of every LN obtained in accordance with standards of care. Prior to the lymph node biopsy by EBUS-TBNA, elastography will be performed. The relative strain of tissues in the scanned area of the LNs will be displayed as a colour map, with stiffer areas in blue and softer tissue in red. Elastography and B-mode images will be displayed side by side and images recorded and saved onto an external drive for analysis. Elastography images will be fed to the NeuralSeg algorithm which has a network architecture similar to the standard U-Net for image segmentation. The automatically identified regions of interest will be overlaid onto the EBUS Elastography images to extract the LN stiffness measurements. After overlaying, NeuralSeg will determine the proportion of the LN area within 9 previously defined stiffness thresholds.
Study NCT05551793 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dupilumab
Description: Dupilumab: 300mg SC injections
Study NCT05551793 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo: SC injections of equivalent volume
Study NCT05521009 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control grup, sticky tube holder
Description: In patients using adhesive tube holders and non-adhesive tube holders, it will be investigated whether there is bacterial growth on the tube.
Study NCT05949918 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stage-matched interventions
Description: The study intervention will be designed based on each Stage of Change of the Transtheoretical Model of Change in that participants in each Stage of Change will receive the intervention that matches the Stage of Change they would be in.~A 12-week interval would be considered between administering the intervention and posttest 1 and the same interval would be used between posttest 1 and posttest 2.
Study NCT05498740 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Drug eluting Balloon
Description: Drug eluting Balloon is a kind of the product that has been used for many years. By filling the micropores on the surface of the balloon with anti-proliferative drugs like immunosuppressive agents, the balloon is expanded and contacted with the lesion to rapidly release the drug to the local arterial wall.
Study NCT06024551 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telerehabilitation
Description: Patients in this arm will be given telerehabilitation three times a week, for four weeks.
Study NCT06024551 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: home exercise program
Description: Patients in this arm will receive home exercise program for four weeks
Study NCT05182450 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mango leaf extract capsule
Description: Single dose
Study NCT05182450 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo capsule
Description: Single dose
Study NCT05116618 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: InVisionFirst-Lung ctDNA assay
Description: An enhanced tagged/targeted-amplicon sequencing technology for detection of genomic alterations in 36 commonly mutated genes in plasma ctDNA with a sensitivity of 73.9% and specificity of 99.8%.
Study NCT05445258 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: InnoCath AB® hyper-compliant balloon catheter
Description: endovascular treatment of lesions in the superficial femoral artery (SFA) and/or popliteal artery pars I/II without further luminal widening, and/or for short-term interruption of blood flow with the InnoCath AB® hyper-compliant balloon cathe-ters (100 or 200 mm length)
Study NCT04923334 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief Pain Teleconsult
Description: The Brief Pain Teleconsult intervention includes 2 sessions provided by a licensed physical therapist over about 1 week. The sessions focus on pain education from a biopsychosocial perspective that is designed to address negative pain appraisals and catastrophizing thoughts, providing advice to be active and engage in exercise and physical activity, and reassurance that activity is beneficial and safe.
Study NCT04923334 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telehealth Physical Therapy
Description: The Telehealth Physical Therapy intervention involves weekly telehealth sessions provided over 10 weeks. Telehealth Physical Therapy is provided by a licensed physical therapist. Key components of the intervention include reinforcing biopsychosocial education messages and developing an exercise and physical activity program using cognitive behavioral principles such as goal setting and positive reinforcement. Pain coping strategies including mindful breathing and progressive relaxation techniques will be included.
Study NCT05657899 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cerclage fixation
Description: The intervention is by surgical open reduction and internal fixation of the fracture using two 1.0mm cerclage.
Study NCT05657899 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Tension band wiring
Description: The intervention is by surgical open reduction and internal fixation of the fracture using a 1.0mm cerclage and two 1.6 mm k-wires as described in AO-guidelines.
Study NCT05356273 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Baby massage
Description: Starting from the baby's face first, then the abdomen and chest, back, upper extremities and finally the lower extremities were massaged with semi-circular movements, respectively.
Study NCT06488690 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: All patients who were pregnant and underwent cesarean section
Description: Our study aims to evaluate the use of early warning scores as a screening tool to predict obstetric mortality and morbidity in pregnant women who will undergo cesarean section.
Study NCT05712577 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: Rosenberg Self- Esteem scale
Study NCT05712577 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: Short Form 36 scale
Study NCT05712577 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: Coping orientation to the problems experienced - New Version in Italian
Study NCT05712577 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: Outcome Questionnaire - version 42.5
Study NCT05701839 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: face mask ventilation
Description: In participants with face mask ventilation, oxygen inhaled through face mask at a flow rate of 5 L/min.
Study NCT05701839 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: nasopharyngeal tube ventilation
Description: In participants with nasopharyngeal tube ventilation, oxygen inhaled through face mask before induction and through nasopharyngeal tube after consciousness disappear at a flow rate of 5 L/min.
Study NCT05701839 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: oxygen saturation monitoring
Description: In participants with oxygen saturation monitoring, assist ventilation through face mask will be performed when oxygen saturation drops to 95%, it lasts for another 10 seconds when oxygen saturation restores to 100%.
Study NCT05701839 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: oxygen reserve index monitoring
Description: In participants with oxygen reserve index monitoring, assist ventilation through face mask will be performed when oxygen reserve index drops to 0.1, it lasts for another 10 seconds when oxygen reserve index restores to 0.1.
Study NCT04729153 — intervention group
Intervention type: DRUG
Intervention: DAAD Compound
Description: Sofosbuvir , Daclatasvir and ribavirin
Study NCT04608292 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Single-voxel MRS
Description: Diagnostic test is a single voxel MRS scan
Study NCT04608292 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Multi-voxel MRSI
Description: Diagnostic test is a multi-voxel MRS imaging scan
Study NCT04608292 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Magnetization Transfer Imaging
Description: Diagnostic test is a set of magnetic transfer weighted images
Study NCT04938271 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HEAL-122 microcurrent electroceutical with e-textile sports knee sleeve
Description: Using a bluetooth connected iPhone, subject activates the HEAL-122 electroceutical device that is docked onto an e-textile sports knee sleeve worn on the osteoarthritic knee
Study NCT04008199 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Super Abbu
Description: The investigators have developed, piloted, and propose to expand and to experimentally evaluate a speech-based service that connects expectant fathers to doctors and to each other over a simple phone call. This service is dubbed Super Abbu (Super Dad in English).
Study NCT04608292 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Alcohol ingestion
Description: Participants will ingest an ethanol-containing beverage of approximately 0.5g/kg of ethanol mixed in 355 mL of a non-caffeinated, sugar-free carbonated drink which must be consumed in 5 minutes
Study NCT04608292 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ClearMate
Description: Participants will breathe through the ClearMate, an MR-compatible non-rebreathing circuit which provides oxygen and carbon dioxide that quickly decreases a person's blood alcohol level.